{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:45:45Z","timestamp":1790747145891,"version":"4.1.0"},"reference-count":29,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2025,8,7]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Pipeline Vantage 027 flow diverter became available a year ago in the United States. We report an observational study of its safety and early angiographic response in the treatment of internal carotid artery (ICA) aneurysms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients treated with the Vantage 027 for ICA aneurysms from April to November 2024 at a single center were included. Intraprocedural contrast-enhanced cone-beam CT was used to evaluate vessel wall apposition. A novel proximal ledge deformity is defined as delayed elevation of one stent edge into the lumen while the opposite edge remains wall-apposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four aneurysms (mean size 4.2\u00b12.7\u2009mm) in 20 patients underwent Vantage 027 embolization. Clinical follow-up at 6 months revealed no major\/minor stroke and a single reversible ischemic attack following dual anti-platelet therapy (DAPT) non-compliance. Follow-up angiography in all patients revealed complete occlusion in 19\/24 aneurysms at a median of 3.5\u2009months (79%). Severe \u226550% stenosis was noted in 7\/20 (35%) with distal fishmouth deformity in 12\/20 (60%); both fishmouthing (p=0.003) and severe stenosis (p=0.04) were associated with younger age. We also observed a proximal ledge in 5\/20 (25%) with luminal caliber compromise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although Vantage 027 ICA aneurysm embolization resulted in early robust aneurysm involution, it was associated with an age-dependent fishmouthing braid deformity and a proximal ledge deformity possibly requiring extended DAPT. These results encourage further analysis of the vascular response to Vantage 027 and similar stents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2025-023567","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:55:20Z","timestamp":1756713320000},"page":"1625-1631","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Early angiographic response to Pipeline Vantage flow diverter embolization of intracranial carotid aneurysms"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-2615","authenticated-orcid":false,"given":"M Harrison","family":"Snyder","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular and Endovascular Division, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-7609","authenticated-orcid":false,"given":"Adel M","family":"Malek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular and Endovascular Division, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"2026061805451089000_18.7.1625.1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2421"},{"key":"2026061805451089000_18.7.1625.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-021120"},{"key":"2026061805451089000_18.7.1625.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-021404"},{"key":"2026061805451089000_18.7.1625.4","doi-asserted-by":"crossref","unstructured":"Goertz L , Hohenstatt S , Zopfs D , et al . Pipeline vantage embolization device for the treatment of intracranial aneurysms: a systematic review and meta-analysis. Interv Neuroradiol 2024. doi:10.1177\/15910199241264340","DOI":"10.1177\/15910199241264340"},{"key":"2026061805451089000_18.7.1625.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-021182"},{"key":"2026061805451089000_18.7.1625.6","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018480"},{"key":"2026061805451089000_18.7.1625.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-023-01314-x"},{"key":"2026061805451089000_18.7.1625.8","doi-asserted-by":"crossref","unstructured":"D\u00f6ring K , Aburub A , Krauss JK , et al . Early clinical experience with the new generation Pipeline Vantage flow diverter in the treatment of unruptured saccular aneurysms using short-term dual antiplatelet therapy. Interv Neuroradiol 2023;15910199231205047. doi:10.1177\/15910199231205047","DOI":"10.1177\/15910199231205047"},{"key":"2026061805451089000_18.7.1625.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020754"},{"key":"2026061805451089000_18.7.1625.10","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.wneu.2023.12.057","article-title":"Aneurysm treatment with the pipeline vantage embolization device in retrospective evaluation: periprocedural results from the pipe-VADER study","volume":"183","author":"Goertz","year":"2024","journal-title":"World Neurosurg"},{"key":"2026061805451089000_18.7.1625.11","unstructured":"U.S. Food & Drug Administration . Embolization Device Recall and Correction: Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device with Shield Technology, Updates Use Instructions for 021 Compatible Pipeline Vantage Embolization Devices due to Increased Risk of Incomplete Wall Apposition and Braid Deformation. 2025. Available: https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls\/embolization-device-recall-and-correction-medtronic-removes-unused-027-compatible-pipeline-vantage"},{"key":"2026061805451089000_18.7.1625.12","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199603000-00001"},{"key":"2026061805451089000_18.7.1625.13","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2014-011258"},{"key":"2026061805451089000_18.7.1625.14","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-015943"},{"key":"2026061805451089000_18.7.1625.15","doi-asserted-by":"crossref","unstructured":"Chia GS , de Villiers L , Carraro do Nascimento V , et al . Safety and clinical effectiveness of pipeline shield device for intracranial aneurysms in an australian cohort (SCOPE\u2010AUS). Stroke Vasc Interv Neurol 2022;2. doi:10.1161\/SVIN.121.000292","DOI":"10.1161\/SVIN.121.000292"},{"key":"2026061805451089000_18.7.1625.16","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018501"},{"key":"2026061805451089000_18.7.1625.17","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6314"},{"key":"2026061805451089000_18.7.1625.18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2176\/jns-nmc.2022-0217","article-title":"Pipeline flex with shield technology placement for small- and medium-sized aneurysms achieves early complete occlusion","volume":"63","author":"Arai","year":"2023","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2026061805451089000_18.7.1625.19","doi-asserted-by":"crossref","first-page":"123336","DOI":"10.1016\/j.jns.2024.123336","article-title":"Comparative analysis of safety and efficacy of flow diversion with and without surface modification technology, FRED-X, FRED, PED shield and PED in 386 patients: a single center experience with systematic review and network meta analysis","volume":"468","author":"Roy","year":"2025","journal-title":"J Neurol Sci"},{"key":"2026061805451089000_18.7.1625.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-017-0591-y"},{"key":"2026061805451089000_18.7.1625.21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/19714009231224408","article-title":"Safety and efficacy of surpass evolve flow diverter for intracranial aneurysms: a study of 116 patients","volume":"37","author":"Bibi","year":"2024","journal-title":"Neuroradiol J"},{"key":"2026061805451089000_18.7.1625.22","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-011074"},{"key":"2026061805451089000_18.7.1625.23","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-022236"},{"key":"2026061805451089000_18.7.1625.24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/15910199211024061","article-title":"The Silk Vista Baby - The UK experience","volume":"28","author":"Bhogal","year":"2022","journal-title":"Interv Neuroradiol"},{"key":"2026061805451089000_18.7.1625.25","doi-asserted-by":"crossref","unstructured":"Goertz L , Weyland CS , Nikoubashman O , et al . Multicenter study of HPC coated p48 and p64 flow diverters for treatment of intracranial aneurysms under dual antiplatelet therapy. Interv Neuroradiol 2025. doi:10.1177\/15910199251318066","DOI":"10.1177\/15910199251318066"},{"key":"2026061805451089000_18.7.1625.26","doi-asserted-by":"publisher","DOI":"10.3171\/2013.2.JNS121427"},{"key":"2026061805451089000_18.7.1625.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010522"},{"key":"2026061805451089000_18.7.1625.28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocn.2022.06.028","article-title":"Clinical evaluation of high-resolution cone-beam computed tomography for the implantation of flow-diverter stents in intracranial aneurysms","volume":"103","author":"Yu","year":"2022","journal-title":"J Clin Neurosci"},{"key":"2026061805451089000_18.7.1625.29","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-021503"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2025-023567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:45:59Z","timestamp":1781786759000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2025-023567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,18]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/jnis-2025-023567"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2025-023567","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}